216 related articles for article (PubMed ID: 36786552)
1. Phosphorylation at Ser289 Enhances the Oligomerization of Tau Repeat R2.
Man VH; He X; Han F; Cai L; Wang L; Niu T; Zhai J; Ji B; Gao J; Wang J
J Chem Inf Model; 2023 Feb; 63(4):1351-1361. PubMed ID: 36786552
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study.
Man VH; He X; Gao J; Wang J
ACS Chem Neurosci; 2023 Feb; 14(3):458-467. PubMed ID: 36669127
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-Induced Structural Reorganization in Tau-Paired Helical Filaments.
Rani L; Mallajosyula SS
ACS Chem Neurosci; 2021 May; 12(9):1621-1631. PubMed ID: 33877805
[TBL] [Abstract][Full Text] [Related]
4. Probable participation of 14-3-3 in tau protein oligomerization and aggregation.
Sluchanko NN; Gusev NB
J Alzheimers Dis; 2011; 27(3):467-76. PubMed ID: 21876254
[TBL] [Abstract][Full Text] [Related]
5. Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.
Vergara C; Ordóñez-Gutiérrez L; Wandosell F; Ferrer I; del Río JA; Gavín R
Mol Neurobiol; 2015; 51(3):1206-20. PubMed ID: 24965601
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
[TBL] [Abstract][Full Text] [Related]
7. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
8. Oxidized and phosphorylated synthetic peptides corresponding to the second and third tubulin-binding repeats of the tau protein reveal structural features of paired helical filament assembly.
Hoffmann R; Dawson NF; Wade JD; Otvös L
J Pept Res; 1997 Aug; 50(2):132-42. PubMed ID: 9273897
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tau self-aggregation and neurotoxicity.
Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the Effect of pS202/pT205/pS208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein.
Liu H; Li Q; Xiong C; Zhong H; Zhang Q; Liu H; Yao X
ACS Chem Neurosci; 2021 Mar; 12(6):1039-1048. PubMed ID: 33663205
[TBL] [Abstract][Full Text] [Related]
11. On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations.
Fagnen C; Giovannini J; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J
ACS Chem Neurosci; 2022 Oct; 13(19):2874-2887. PubMed ID: 36153969
[TBL] [Abstract][Full Text] [Related]
12. Tau as a therapeutic target for Alzheimer's disease.
Boutajangout A; Sigurdsson EM; Krishnamurthy PK
Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
[TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles and tau phosphorylation.
Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
[TBL] [Abstract][Full Text] [Related]
14. Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.
Qureshi HY; Li T; MacDonald R; Cho CM; Leclerc N; Paudel HK
Biochemistry; 2013 Sep; 52(37):6445-55. PubMed ID: 23962087
[TBL] [Abstract][Full Text] [Related]
15. The Neurotoxic Role of Extracellular Tau Protein.
Sebastián-Serrano Á; de Diego-García L; Díaz-Hernández M
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584657
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
17. Tau, tau kinases, and tauopathies: An updated overview.
Montalto G; Ricciarelli R
Biofactors; 2023; 49(3):502-511. PubMed ID: 36688478
[TBL] [Abstract][Full Text] [Related]
18. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
[TBL] [Abstract][Full Text] [Related]
19. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
20. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
